These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15896465)
1. Functional definition of relevant epitopes on the tumor suppressor PTEN protein. Andrés-Pons A; Valiente M; Torres J; Gil A; Roglá I; Ripoll F; Cervera J; Pulido R Cancer Lett; 2005 Jun; 223(2):303-12. PubMed ID: 15896465 [TBL] [Abstract][Full Text] [Related]
2. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Yuan XJ; Whang YE Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions. Torres J; Rodriguez J; Myers MP; Valiente M; Graves JD; Tonks NK; Pulido R J Biol Chem; 2003 Aug; 278(33):30652-60. PubMed ID: 12788938 [TBL] [Abstract][Full Text] [Related]
4. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. Valiente M; Andrés-Pons A; Gomar B; Torres J; Gil A; Tapparel C; Antonarakis SE; Pulido R J Biol Chem; 2005 Aug; 280(32):28936-43. PubMed ID: 15951562 [TBL] [Abstract][Full Text] [Related]
5. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419 [TBL] [Abstract][Full Text] [Related]
6. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
7. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. Kandasamy K; Srivastava RK Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743 [TBL] [Abstract][Full Text] [Related]
8. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311 [TBL] [Abstract][Full Text] [Related]
9. Expression of PTEN and Caspase-3 and their clinicopathological significance in primary gastric malignant lymphoma. Sun H; Zheng H; Yang X; Wu D; Zhang S; Kuang L; Xin Y Chin Med Sci J; 2004 Mar; 19(1):19-24. PubMed ID: 15104220 [TBL] [Abstract][Full Text] [Related]
10. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408 [TBL] [Abstract][Full Text] [Related]
11. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover. Maehama T; Okahara F; Kanaho Y Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605 [TBL] [Abstract][Full Text] [Related]
12. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines. Goswami R; Singh D; Phillips G; Kilkus J; Dawson G J Neurosci Res; 2005 Aug; 81(4):541-50. PubMed ID: 15968641 [TBL] [Abstract][Full Text] [Related]
13. PTEN-PDZ domain interactions: binding of PTEN to PDZ domains of PTPN13. Sotelo NS; Schepens JT; Valiente M; Hendriks WJ; Pulido R Methods; 2015 May; 77-78():147-56. PubMed ID: 25448478 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues. Torres J; Navarro S; Roglá I; Ripoll F; Lluch A; García-Conde J; Llombart-Bosch A; Cervera J; Pulido R Eur J Cancer; 2001 Jan; 37(1):114-21. PubMed ID: 11165138 [TBL] [Abstract][Full Text] [Related]
15. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163 [TBL] [Abstract][Full Text] [Related]
16. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Georgescu MM; Kirsch KH; Akagi T; Shishido T; Hanafusa H Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10182-7. PubMed ID: 10468583 [TBL] [Abstract][Full Text] [Related]
17. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo. Ge NL; Rudikoff S Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase. Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713 [TBL] [Abstract][Full Text] [Related]